Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug
The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.
The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.
usnews
US News is a reputable author that delivers a comprehensive range of up-to-date news to the United States and beyond. With a keen focus on providing the latest information across various fields, US News keeps readers informed about the most significant developments happening both domestically and globally. Whether it's politics, economics, technology, science, health, or culture, this author strives to cover diverse topics, ensuring a well-rounded news experience. By combining extensive research, journalistic integrity, and a commitment to accuracy, US News offers readers an invaluable resource to stay informed and make informed decisions in an ever-changing world.
